(Press-News.org) WASHINGTON, DC – June 17, 2025 – Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide,* at the end of two years, according to a new head-to-head real-world study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.
Researchers from NYU Langone Health and NYC Health + Hospitals discovered patients who had one of the bariatric procedures lost an average 58 pounds after two years compared to 12 pounds for patients who received a GLP-1 prescription for at least six months (24% total weight loss vs. 4.7%). Patients on continuous GLP-1 therapy for a full year lost more weight, but significantly less than bariatric surgery patients (7% total weight loss).
“Clinical trials show weight loss between 15% to 21% for GLP-1s, but this study suggests that weight loss in the real world is considerably lower even for patients who have active prescriptions for an entire year. We know as many as 70% of patients may discontinue treatment within one year,” said lead study author Avery Brown, MD, a surgical resident at NYU Langone Health. “GLP-1 patients may need to adjust their expectations, adhere more closely to treatment or opt for metabolic and bariatric surgery to achieve desired results.”
The study was a retrospective comparative effectiveness study using the real-world electronic medical record data of NYU Langone Health and NYC Health + Hospitals patients with a body mass index (BMI) of at least 35 who had bariatric surgery (sleeve gastrectomy or Roux en-Y gastric bypass) or were prescribed injectable semaglutide or tirzepatide between 2018 and 2024. After adjusting for age, BMI and co-morbidities using average treatment effect weighting, researchers compared the outcomes of 51,085 GLP-1 and surgical patients. The study was supported by NYU CTSA grant KL2 TR001446 from the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH).
“In future studies we will aim to identify what healthcare providers can do to optimize GLP-1 outcomes, identify which patients are better treated with bariatric surgery versus GLP-1s, and determine the role out-of-pocket costs play in treatment success,” said study senior author and bariatric surgeon Karan R. Chhabra, MD, MSc, Assistant Professor of Surgery and Population Health, NYU Grossman School of Medicine.
About 12% of Americans say they have ever taken a GLP-1 drug, including 6% who say they are currently in treatment. A recent study found that more than half of patients with overweight or obesity (53.6%) discontinued GLP-1 therapy within one year (53.6%), a number that grows to 72.2% by two years. Meanwhile, utilization of metabolic and bariatric surgery remains exceedingly low. According to the ASMBS, more than 270,000 metabolic and bariatric procedures were performed in 2023, which represents only about 1% of those who meet eligibility requirements based on BMI.
“While both patient groups lose weight, metabolic and bariatric surgery is much more effective and durable,” said ASMBS President Ann M. Rogers, MD, FACS, FASMBS, who was not involved in the study. “Those who get insufficient weight loss with GLP-1s or have challenges complying with treatment due to side effects or costs, should consider bariatric surgery as an option or even in combination.”
According to the U.S. Centers for Disease Control and Prevention (CDC), the prevalence of obesity and severe obesity is 40.3% and 9.4%, respectively. Studies show the disease can weaken or impair the body’s immune system and cause chronic inflammation and increase the risk of scores of other diseases and conditions including cardiovascular disease, stroke, type 2 diabetes, and certain cancers.
About Metabolic and Bariatric Surgery
Metabolic, bariatric, or weight-loss surgery such as gastric bypass and sleeve gastrectomy has been shown to be the most effective and long-lasting treatment for severe obesity. The operations improve or resolve diseases including type 2 diabetes, heart disease and high blood pressure and leads to significant and durable weight loss. Its safety profile is comparable to some of the safest and most commonly performed surgeries in the U.S. including gallbladder surgery, appendectomy and knee replacement.
About ASMBS
The ASMBS is the largest organization for bariatric surgeons in the United States. It is a non-profit organization that works to advance the art and science of bariatric surgery and is committed to educating medical professionals and the lay public about bariatric surgery as an option for the treatment of severe obesity, as well as the associated risks and benefits. It encourages its members to investigate and discover new advances in bariatric surgery, while maintaining a steady exchange of experiences and ideas that may lead to improved surgical outcomes for patients with severe obesity. For more information, visit www.asmbs.org.
###
*Semaglutide is the active ingredient in Ozempic and Wegovy and tirzepatide, the active ingredient in Zepbound and Mounjaro.
**COMPARATIVE EFFECTIVENESS OF SEMAGLUTIDE AND TIRZEPATIDE vs BARIATRIC SURGERY Avery Brown, M.D.1, 2, Suhani Patel MPH 2, 3, Alexander Hien Vu, M.D. 2, Eduardo Somoza M.D.1, Tony Mei M.S. 2, Megan Jenkins, M.D. 2, Loic Tchokouani, M.D. 2, Marina Kurian, M.D. 2, Babak Orandi, M.D. Ph.D.2,3, Jeffrey Lipman M.D.1, 2, Julia Park M.D.1, 2, Patricia Chui M.D. Ph.D.1, 2, John Saunders M.D.1, 2, Allan Massie Ph..D. 2,3, Sunita Desai Ph.D. 4, Donglan Zhang Ph.D.4, Dorry Segev, M.D. Ph.D.2,3, 4, George Ferzli, M.D.2, Christine Ren-Fielding, M.D. 2, Manish Parikh, M.D.1, 2, Karan Chhabra, M.D., M.Sc.1,2,3,4
Author Affiliations:
NYC Health+Hospitals/Bellevue, Division of Bariatric and General Surgery, New York, 462 1st Ave, NY, 10016
Department of Surgery, New York University Grossman School of Medicine, 550 1st Ave., New York, NY, 10016
Center for Surgical and Transplant Applied Research, New York University Langone Health
Department of Population Health, NYU Grossman School of Medicine
END
WASHINGTON, DC – June 17, 2025 – People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders compared to those who take weekly injections of GLP-1 anti-obesity medications, according to a new study* presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting. Over a five-year period, the risk of developing cognitive deficits was 54% lower and 18% and 17% lower for anxiety disorders and substance use ...
WASHINGTON, DC – June 17, 2025 – The higher a person’s body mass index (BMI), the higher their risk for complications after bariatric surgery, especially those with BMI of 50 or more, according to a new study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.
Researchers found that the rate of complications increased by an average of 5.56% and serious occurrences rose 3.21% from the lowest BMI category to the highest, with people with a BMI 50 or more the most likely to experience complications of any kind.
The study gives new insights into the risks associated ...
WASHINGTON, DC – June 17, 2025 – Black patients are more likely to experience minor complications after metabolic and bariatric surgery than White patients, according to new study* presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.
Researchers from the Yale School of Medicine found Black patients had a higher overall incidence of minor complications such as dehydration, trips to the emergency department (ED) and infections in ...
The founding director of the institute, Aalto University professor Samuel Kaski has received the European Research Council Advanced Grant to develop new types of machine learning.
Many popular and widely available AI tools appear to be extremely versatile and agile, but there is still a hole in the underlying machine learning, argues Kaski. "The basic tenet of machine learning is to apply a model trained on a learning data set. But that only works if the set is representative of the deployment setting — and that seldom holds, because life happens. Unexpected factors, statistically speaking covariates ...
The Institute of Science and Technology Austria (ISTA) in Klosterneuburg receives over 10 million Euro by the European Research Council (ERC). Four research projects – in astrophysics, neuroscience, brain imaging, and math – were awarded around 2.5 million Euro each in the form of a competitive ERC Advanced Grant. ISTA is one of the most successful institutions at winning grants from this EU funding body.
The European Research Council awards Advanced Grants to “active researchers who have a track-record of significant research achievements.” They are awarded for a period of up to 5 years and for up to 2.5 ...
The future of gene therapy is arriving in the form of intelligent genetic circuits. Diego di Bernardo, Genomic Medicine Program Coordinator at the Telethon Institute of Genetics and Medicine (TIGEM) and Professor of Biomedical Engineering at the University of Naples “Federico II,” has been awarded a prestigious €2.5 million ERC Advanced Grant for DIMERCIRCUITS — a project that merges synthetic biology, artificial intelligence, and biomedical engineering to transform how we ...
Scientists have used clues locked into tree rings to reveal major changes in the Amazon’s rainfall cycle over the last 40 years: wet seasons are getting wetter and dry seasons drier.
Oxygen isotope signals in rings from two Amazon tree species allowed the international research team to reconstruct seasonal changes in rainfall for the recent past.
Publishing their findings today (17 June) in Communications Earth and Environment, the researchers reveal that wet season rainfall has increased by 15 - 22%, and dry season rainfall decreased by 5.8 - 13.5% since 1980.
The study is a result of a collaboration ...
Plants and trees extend their roots into the earth in order to draw nutrients and water from the soil—however, these roots are thought to decline as they move deeper underground. But a new study by a multi-institutional team of scientists shows that many plants develop a second, deeper layer of roots—often more than three feet underground—to access additional nourishment.
Published in the journal Nature Communications, the study reveals previously unrecognized rooting patterns, altering our understanding of how ecosystems
respond to changing environmental conditions. More importantly, the study suggests that plants might transport and store fixed carbon deeper than ...
Osaka, Japan – Treating rare diseases can be complicated at the best of times, and it gets even more complicated when different patients with the same disease exhibit different symptoms. Now, researchers from Japan have reported a cellular signature that might explain why some patients with autoimmune disease are stable while others face life-threatening complications.
In a study to be published in Nature Communications, a multi-institutional research team led by The University of Osaka has revealed that, for patients with systemic sclerosis, this variation in disease severity seems to be due to the proliferation ...
WASHINGTON -- Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other complications. Now a new study by scientists from Georgetown University and MedStar Health describes how a single blood sample can be used to catch problems at the earliest stages, allowing tailored treatment to prevent the organ’s failure.
The research, funded in part by the National Institutes of Health, is a major step toward the development of a liquid biopsy that could not only quickly detect post-transplant complications but also ...
